Because it allows physicians to create meaning in their medical practice, finding one’s niche may protect against burnout and other negative effects of work-related stress.
An eye-tracking test has identified a potential performance-based biomarker for the early diagnosis of autism spectrum disorder (ASD).
Clinical experts offer a compilation of research findings regarding the risk and management of ocular adverse events associated with MEK and BRAF inhibitor use.
Blood tests for Alzheimer disease may improve diagnostic accuracy and treatment options.
Oncology professionals share what #MedTwitter means to them and where they might go if Twitter (now X) becomes obsolete.
Pharmaceutical experts explain the associations between antibody-drug conjugates — a class of systemic cancer drugs — and ocular adverse effects.
Although convenient access to health information online has the potential to improve outcomes as the result of patients being more informed, ensuring the accuracy of that information is challenging.
Nathan Scott, MD, of Shiley Eye Institute, provides an overview of this modern class of cancer therapies and strategies for keeping patients using them in good ocular and visual health.